Serum S-100 protein in acute stroke.

نویسندگان

  • R J Butterworth
  • R A Sherwood
  • P M Bath
چکیده

To the Editor: We read with interest the work of Missler et al1 and Büttner and colleagues2 and agree with both sets of researchers on the need for reliable, noninvasive markers of neuronal damage following acute stroke. Such markers may allow prognostication of future clinical outcome and may be useful in acute therapy trials as surrogate markers of efficacy. However, neither study cited our publication on serum S-100 protein levels in acute stroke,3,4 a study that examined 81 patients (68 with ischemic stroke and 13 with hemorrhagic stroke) within 48 hours of stroke ictus and compared them with 51 age-, race-, and gendermatched control subjects.3 As with both recent papers in Stroke, we found significantly higher serum S-100 protein levels in the stroke population than in the control group. Furthermore, the highest S-100 protein levels were seen in the hemorrhagic stroke group, and differentiation between the two stroke populations almost reached statistical significance. We also performed a temporal study (24, 48, 72, and 96 hours after ictus) in 13 patients and, unlike the recent Stroke studies, did not find differences between these time points. Convalescent samples were also analyzed in 57 of the 74 patients still alive at 3 months after stroke; S-100 protein levels had significantly fallen (2 P,.0001) at this time but were still above the level seen in the control population, suggesting partial restoration of glial cell integrity. We have previously shown5 that neuron-specific enolase level and carnosinase activity are individually associated with clinical outcome, determined with use of the Rankin Scale score and Barthel Index, although their ratio has the strongest association. We also found that S-100 levels were associated with clinical outcome.3 The results of our S-100, neuron-specific enolase, and carnosinase activity work and the recent S-100 protein studies show that serum biochemical markers can be readily measured using commercially available assays and appear to provide useful prognostic information. We believe the combination of the results of two (or more) markers, as used in our neuron-specific enolase/human serum carnosinase article,5 may improve their usefulness and reliability. We are currently assessing whether early drug therapy can modulate these serum markers in patients with acute stroke, thereby supporting their use as surrogate markers of efficacy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Incidence and Clinical Outcome of Patients with Hypertensive Acute Ischemic Stroke: An Update from Tertiary Care Center of Central India

Introduction: We evaluated the incidence and clinical outcome of patients with hypertensive acute ischemic stroke (AIS) admitted to a tertiary care center in Central India. In addition, we examined the status of stroke biomarkers namely neuron-specific enolase (NSE), glial specific protein (S-100ββ), and inter-α-trypsin inhibitor heavy chain 4(ITIH4) in the serum of patients suf...

متن کامل

The Relation between GABA and L-Arginine Levels with some Stroke Risk Factors in Acute Ischemic Stroke Patients

Changes in extra and intracellular neurotransmitter amino acids concentration in the early stage of acute cerebral ischemia have been reported. In this the study, serum level of gamma aminobutyric acid (GABA) and L-Arginine in acute ischemic stroke patients was assessed. 60 patients with acute ischemic stroke and sixthy healthy volunteers as a control group were assessed. Serum GABA was measure...

متن کامل

Ability of serum C-reactive protein and white blood cell cout in predicting acute schemic stroke. A short -term follow-up study

Background: Stroke is one of the leading causes of mortality and long-term morbidity. The aim of the present study was to determine the ability of baseline serum C-reactive protein (CRP) and white blood cell count (WBC) values in predicting the outcome of acute ischemic stroke (AIS). Methods: This study consisted of patients with first AIS referred to Poursina Hospital, Rasht, Iran. Severity...

متن کامل

ارتباط سطح سرمی پروتئین واکنشگر C-با تنگی عروق داخل و خارج مغزی در بیماران مبتلا به سکته مغزی ایسکمیک حاد

Background and Objective: Previous studies have been shown that serum level of C-reactive protein (CRP) is significantly correlated with mortality and functional outcome in patients with ischemic stroke. Some studies point to specific vessels involvement according to different serum level CRP. The aim of this study was to investigate the association between serum C-reactive protein level ...

متن کامل

Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia.

BACKGROUND AND PURPOSE The aim of our study was to assess the use of S-100 protein (S-100) and neuron-specific enolase (NSE) in serum and cerebrospinal fluid (CSF) for the prediction of patients' regaining consciousness after acute global cerebral ischemia. METHODS Sixty-four unconscious patients were followed until the return of consciousness or until death/vegetative state. Serum and CSF sa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Stroke

دوره 29 3  شماره 

صفحات  -

تاریخ انتشار 1998